Control comparison, M6 showed highly significant elevation (FDR-adjusted p = 0.00018), followed by A2BG1S1 (FDR-adjusted p = 0.0062) and M5 (FDR-adjusted p = 0.0296).
Excerpts
A highly significant 0.9-fold increase (71.3 ± 4%; p = 0.0002; n = 3) was evident in similar T cells post exposure to CGM from CeD-MoDCs ( Figure 3 A, right).
The clustering analysis based on network proteins showing increased levels in the NPM1-Ins patients showed that all except one of the patients with NPM1-Ins clustered together in the same main patient cluster, characterized by generally high levels of these proteins ( Figure 3 ); this difference in distribution of NPM1-Ins patients between the two main patient clusters is highly significant (Fisher’s exact test, p = 0.0002).
The Kruskal–Wallis test indicated a highly significant difference in MPO expression among the groups (H = 16.29, p = 0.00029), with mean rank scores of 5.5 for Group A, 17.71 for Group B, and 9.79 for Group K.
From post hoc comparisons, no significant comparisons within genotypes (both within G/G and within G/A) are observed, while highly significant is the comparison between G/G and G/A genotypes ( p < 0.0003), thus highlighting that the highest HbF induction was found in G/A rs368698783 genotypes. 2.2.
High) was 4.86-fold, and was highly significant ( p -value = 0.0003).
The results revealed an overall highly significant increase in the expression levels of miR-155-5p in patients compared to controls ( p = 0.0003) ( Figure 3 A).
However, in the SN ipsilateral to lesion, there were highly significant increases in extracellular DA in the SN after K + -infusion in striatum (F(1,11) = 27.9, p = 0.0003; Figure 6 F), with extracellular DA increasing by ~7-fold within the first 20 min.
The levels of VLDLR-AS1 were lower in the rmTBI samples compared to the no lifetime TBI samples, and this difference was highly significant ( p = 0.0004), indicating that VLDLR-AS1 is a strong, viable indicator of rmTBI.
Indeed, Spearman’s correlation analysis of the OMAP index and pregnenolone production in U87MG cells treated with micromolar concentrations of the compounds revealed a highly significant p value ( p = 0.0004, Figure 3 ).
In all these comparisons, the difference between control antibody and fremanezumab was highly significant (F 1,62/64 = 21.40–23.68, p < 0.0005) but there was no difference between the three trigeminal partitions V1-V3 (F 2,62 = 0.80, p = 0.45), between females and males (F 1,64 = 0.65, p = 0.42) and between different waiting times (F 1,64 = 0.64, p = 0.43).
There was an increasing trend in iNOS expression at 12 h and 24 h, reaching a maximum value at 24 h ( Figure 2 l, 9.04 ± 0.19 vs. 19.05 ± 3.02, p = 0.0005).
The effect of time was highly significant ( p < 0.0005) for all fatty acids, except for C22:6ω3, where the effect was significant at a level of p = 0.036.
The reduction was highly significant, with MDA-MB-231 cells showing p < 0.0005 and MCF7 cells exhibiting p < 0.0001.
Both differences were highly significant ( P = 0.0006 and P < 0.0001, Figure 1 A,B).
Friedman ANOVA showed highly significant changes in cortical mRNA expression of all targeted genes—Il1b ( p = 0.0007), TNF ( p = 0.00002), Il6 ( p = 0.0015), TGFb ( p = 0.0098), Panx1 ( p = 0.0001), and CGRP ( p = 0.0039)—at three hours after the injury.
Normo-weighted subjects showed a highly significant decrease in periodontal inflammation (PISA index) (986.99 mm 2 ± 591.47 vs. 477.28 mm 2 ± 542.55, p = 0.0007) after periodontal treatment, shifting from a severe state of periodontitis to a mild state of periodontitis ( Figure 3 ).
This distribution resulted in a highly significant difference (Fisher’s exact test, p = 0.0007) ( Table 3 ).
A significant difference in reaction times was found between Byblis -1 (C&M) and Byblis -2 (C) (one-way analysis of variance, F(3.36) = 7.779, p = 0.0353206, Tukey HSD post-hoc testing); very significant differences were found between Byblis -1 (C) and Bybils -2 (C&M) (One-way Analysis of Variance, F(3,36) = 7.779, p = 0.0046993, Tukey HSD post-hoc testing); and extremely significant differences were found between Byblis -1 (C&M) and Byblis -2 (C&M) (One-way Analysis of Variance, F(3,36) = 7.779, p = 0.0007705, Tukey HSD post-hoc testing).
For miRlastic, the test yielded a highly significant p -value of p = 8 . 736821 × 10 - 4 .
When this cohort was stratified based on low and high FABP12 expression levels, the association between BIRC5 and patient survival became insignificant in the subpopulation with low levels of FABP12 (HR = 2.22, p = 0.56; Figure 6 E), but remained highly significant in the subpopulation with high levels of FABP12 (HR = 4.28, p = 0.0009; Figure 6 F).
ANOVA showed that sample type had a highly significant effect on CUPRAC ( p < 0.001), and post hoc comparisons indicated that spray samples differed significantly from the lowest categories ( p < 0.05).
Considering the iAUC for serum leptin in the 0–4 h postprandial lap, this difference among the study groups became highly significant ( p < 0.001) ( Figure 2 B).
The comparison reveals a highly significant presence of AQP8 in the NR group compared with the R group at T0 ( p < 0.001) in MVs.
The results were considered significant if p < 0.05 (*), very significant if p < 0.01 (**), or highly significant if p < 0.001 (***). 5.